Conversion of vascular endothelial cells into multipotent stem-like cells

被引:0
|
作者
Damian Medici
Eileen M Shore
Vitali Y Lounev
Frederick S Kaplan
Raghu Kalluri
Bjorn R Olsen
机构
[1] Beth Israel Deaconess Medical Center,Division of Matrix Biology, Department of Medicine
[2] Harvard Medical School,Department of Orthopaedic Surgery
[3] University of Pennsylvania School of Medicine,Department of Genetics
[4] University of Pennsylvania School of Medicine,Department of Medicine
[5] Center for Research in Fibrodysplasia Ossificans Progressiva and Related Disorders,Department of Biological Chemistry and Molecular Pharmacology
[6] University of Pennsylvania School of Medicine,Department of Developmental Biology
[7] University of Pennsylvania School of Medicine,undefined
[8] Harvard Medical School,undefined
[9] Harvard–Massachusetts Institute of Technology Division of Health Sciences and Technology,undefined
[10] Harvard School of Dental Medicine,undefined
来源
Nature Medicine | 2010年 / 16卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Under certain conditions, endothelial cells can transform into mesenchymal cell types, a process known as endothelial-to-mesenchymal transition. Damian Medici et al. now provide evidence that this type of transition contributes to the generation of the ossified lesions of individuals with fibrodysplasia ossificans progressiva. Experiments in mice and in cultured endothelial cells indicate that activation of the ALK2 receptor in endothelial cells endows them with the ability to differentiate into a number of cell types.
引用
收藏
页码:1400 / 1406
页数:6
相关论文
共 50 条
  • [41] Temozolomide-induced conversion of glioma cells into glioma "stem-like" cells with enhanced invasion properties
    Ahmed, Atique U.
    Auffinger, Brenda
    Tobias, Alex
    Thaci, Bart
    Han, Yu
    Lesniak, Maciej S.
    CANCER RESEARCH, 2013, 73 (08)
  • [42] Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
    B Auffinger
    A L Tobias
    Y Han
    G Lee
    D Guo
    M Dey
    M S Lesniak
    A U Ahmed
    Cell Death & Differentiation, 2014, 21 : 1119 - 1131
  • [43] Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
    Auffinger, B.
    Tobias, A. L.
    Han, Y.
    Lee, G.
    Guo, D.
    Dey, M.
    Lesniak, M. S.
    Ahmed, A. U.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (07): : 1119 - 1131
  • [44] Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions
    Snyder, EY
    Macklis, JD
    CLINICAL NEUROSCIENCE, 1996, 3 (05) : 310 - 316
  • [45] Danger and benefit of vascular wall resident endothelial pre-cursor/multipotent stem cells
    Erguen, S.
    JOURNAL OF VASCULAR RESEARCH, 2006, 43 (06) : 534 - 534
  • [46] Differentiation of Human Multipotent Vascular Stem Cells Contributes to Vascular Diseases
    Huang, Wen-Chin
    Wang, Aijun
    Li, Song
    CIRCULATION RESEARCH, 2015, 117
  • [47] Effect of hyperthermia on the cancer stem-like cells
    Shimoji, Miyuki
    Murata, Satoshi
    Sihombing, Andreas M.
    Takebayashi, Katsushi
    Kodama, Hirokazu
    Kojima, Masatsugu
    Ueki, Tomoyuki
    Kitamura, Naomi
    Kitamura, Mina
    Tokuda, Aya
    Miyake, Toru
    Mekata, Eiji
    Tani, Masaji
    CANCER SCIENCE, 2021, 112 : 571 - 571
  • [48] HETEROGENEITY OF STEM-LIKE CELLS IN HEPATOCELLULAR CARCINOMA
    Mazzucchelli, S.
    Baldan, F.
    Colombo, F.
    Martin-Padura, I.
    Marighetti, P.
    Cattaneo, A.
    Rossi, G.
    Mazzaferro, V.
    Foglieni, B.
    Spreafico, M.
    Bertolini, F.
    Prati, D.
    Porretti, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S9 - S9
  • [49] Eradication of cancer stem-like cells in PDAC
    Arumugam, Thiruvengadam
    Ramachandran, Vijaya
    Logsdon, Craig
    CANCER RESEARCH, 2015, 75
  • [50] Inflammatory regulation of stem-like cells in melanoma
    Lim, Ming-Sheng
    Wang, Jiang Huai
    Power, Derek G.
    Redmond, H. Paul
    MELANOMA RESEARCH, 2017, 27 (01) : 1 - 7